CFC Planning »

Aeglea Biotherapeutics shares owned by CFC Planning

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by CFC Planning from 13F filings

Historical chart of CFC Planning investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by CFC Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by CFC Planning

Quarter filed Position value Share count Share price at filing
2026-06-30 $202k 2.3k 88.78

More positions owned by CFC Planning

Apple (AAPL)
Cisco Systems (CSCO)
Southern Copper Corporation (SCCO)
UnitedHealth (UNH)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Philip Morris International (PM)
American Express Company (AXP)
Walt Disney Company (DIS)
Texas Instruments Incorporated (TXN)
Johnson & Johnson (JNJ)
Altria (MO)
Coca-Cola Company (KO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Verizon Communications (VZ)
Visa Com Cl A (V)

View all positions for CFC Planning

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics